검색
검색 팝업 닫기

Ex) Article Title, Author, Keywords

Article

Original Article

Clinical Pain 2022; 21(2): 109-113

Published online December 31, 2022 https://doi.org/10.35827/cp.2022.21.2.109

Copyright © Korean Association of Pain Medicine.

Intramedullary Spinal Cord Hemorrhage Associated with Monoparesis after Transforaminal Cervical Epidural Steroid Injection

경추부 경추간공 경막외 스테로이드 주사 이후 발생한 척수내 출혈

Mi Rim Suh, M.D., Yongbum Park, M.D., Seok Hyeon Lee, M.D., Dong Yuk Lee, M.D. and Jaeki Ahn, M.D., Ph.D.

서미림ㆍ박용범ㆍ이석현ㆍ이동녘ㆍ안재기

Department of Rehabilitation Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea

인제대학교 상계백병원 재활의학과

Received: May 20, 2022; Revised: July 10, 2022; Accepted: August 1, 2022

Abstract

Transforaminal cervical epidural steroid injection (TFCESI) is widely used as conservative treatment for cervical radiculopathy, but severe complications associated with this procedure have been reported. This report was the first case of intramedullary spinal cord hemorrhage following TFCESI. A 67-year-old woman presented with weakness and sensory disturbance in left upper extremity after TFCESI. Cervical magnetic resonance imaging revealed intramedullary spinal cord hemorrhage accompanied by myelopathy at the C2∼C5 level. The patient was administered intravenous methylprednisolone daily (1,000 mg/8 hours) for 5 days and was subsequently transferred to the Department of Rehabilitation Medicine for rehabilitation therapy. A month later, the patient’s neurological impairment partially improved. Although TFCESI is rarely associated with major complications, physicians should be cautious when performing the procedure, and remain mindful of the potentially serious complications.

KeywordsRadiculopathy, Injection, Spinal cord vascular diseases

Korean Association of Pain Medicine

Vol.23 No.2
December 2024

eISSN: 2765-5156

Frequency: Semi Annual

Current Issue   |   Archives

Stats or Metrics

Share this article on :

  • line